ICI-201

N/A

Report date: 2023/12/23 20:00:46

Base Information

Drug NameICI-201

Drug Alias NameICI201 CAR-T cellICI-201ICI201

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaDiscontinued

Originator CompaniesThe First Affiliated Hospital Of Soochow University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe First Affiliated Hospital Of Soochow University

Active IndicationsN/A

Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A